MedAvail Holdings, Inc. (MDVLQ) Research

MedAvail Holdings, Inc. operated as a technology-driven provider of retail pharmacy services and solutions across the United States and Canada. The company specialized in developing and bringing to market self-service pharmacy systems, mobile applications, and kiosk-based solutions. A primary offering was the MedAvail MedCenter, an advanced pharmacy technology designed to facilitate on-site prescription dispensing. This system allowed for direct medication access in various settings, including medical clinics, retail environments, and employer sites, utilizing an audio-visual link that provided real-time supervision and consultation from a licensed pharmacist during dispensing. The corporate headquarters for MedAvail Holdings, Inc. were situated in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc., along with its affiliated entities, submitted a voluntary petition for Chapter 7 liquidation to the U.S. Bankruptcy Court for the District of Delaware.

Market snapshot

Symbol
MDVLQ
Price
$0.00
Day change
0.00%
Market cap
$2.9M
P/E ratio
-0.05x
52-week range
0.0001-0.0002
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Next earnings
in 2 months

Peer companies

  • Biocept, Inc. (BIOCQ)
  • Biostar Pharmaceuticals, Inc. (BSPM)
  • Eloxx Pharmaceuticals, Inc. (ELOX)
  • Cue Health Inc. (HLTHQ)
  • HTG Molecular Diagnostics, Inc. (HTGMQ)
  • Micron Solutions, Inc. (MICRD)
  • Nabriva Therapeutics plc (NBRVF)
  • NexImmune, Inc. (NEXI)

Open MedAvail Holdings, Inc. (MDVLQ) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.